Impact of Model for End-Stage Liver Disease Score on Long-Term Survival Following Liver Transplantation for Hepatocellular Carcinoma

2012 ◽  
Vol 44 (8) ◽  
pp. 2423-2427 ◽  
Author(s):  
J. Roma ◽  
E. Balbi ◽  
L. Pacheco-Moreira ◽  
I. Zyngier ◽  
A. Araujo ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Liver Disease ◽  
Disease Score ◽  
Term Survival ◽  
Long Term Survival ◽  
End Stage Liver Disease ◽  
End Stage

Increased Long-term Survival Among Patients With Hepatocellular Carcinoma After Implementation of Model for End-stage Liver Disease Score

2014 ◽  
Vol 12 (9) ◽  
pp. 1534-1540.e1 ◽  
Author(s):  
Robert J. Wong ◽  
Pardha Devaki ◽  
Long Nguyen ◽  
Ramsey Cheung ◽  
Cheryl Cho–Phan ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Disease ◽  
Disease Score ◽  
Term Survival ◽  
Long Term Survival ◽  
End Stage Liver Disease ◽  
End Stage

Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma

2019 ◽  
Vol 8 (12) ◽  
pp. 993-1002
Author(s):  
Nima Kokabi ◽  
Nariman Nezami ◽  
Minzhi Xing ◽  
Johannes M Ludwig ◽  
Mario Strazzabosco ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Overall Survival ◽  
Liver Disease ◽  
Organ Procurement ◽  
Group Versus ◽  
Disease Score ◽  
End Stage Liver Disease ◽  
End Stage ◽  
United Network

Aim: To simulate effects of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy on the patients’ characteristics and post orthotopic liver transplantation (OLT) outcome. Materials & methods: The United Network for Organ Sharing database was used to identify patients with hepatocellular carcinoma who were listed for OLT 2002–2014. All patients (actual group) versus simulated group with new 6-month delay in assigning Model for End-Stage Liver Disease score exception and Model for End-Stage Liver Disease exception cap of 34 were compared. Results & conclusion: With the new policy, 7,745 (30.4%) of the transplanted patients would have received a delayed transplantation or not be transplanted. The simulated group also showed significantly higher mean overall survival after OLT (p < 0.002) and received more locoreginal treatments (p < 0.001).

Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome

2016 ◽  
Vol 28 (2) ◽  
pp. 153-158 ◽  
Author(s):  
Andrej Khandoga ◽  
Emil Iskandarov ◽  
Martin Angele ◽  
Alexander Gerbes ◽  
Lorenz Frey ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Liver Disease ◽  
Disease Score ◽  
Term Outcome ◽  
Long Term Outcome ◽  
End Stage Liver Disease ◽  
End Stage

Liver Transplantation for the Gastroenterologist

2015 ◽  
Author(s):  
Andreea M. Catana ◽  
Michael P. Curry
Keyword(s):  
United States ◽  
Liver Transplantation ◽  
Liver Disease ◽  
Organ Procurement ◽  
The United States ◽  
Waiting Lists ◽  
Liver Graft ◽  
Term Survival ◽  
End Stage Liver Disease ◽  
End Stage

The first liver transplantation (LT) was performed in 1963, and currently more than 65,000 people in the United States are living with a transplanted liver. In 2012, the number of adults who registered on the LT waiting list decreased for the first time since 2002; 10,143 candidates were added compared with 10,359 in 2011. LT offers long-term survival for complications of end-stage liver disease and prolongs life in properly selected patients, but problems such as donor deficit, geographic disparities, and long waiting lists remain. This overview of LT for the gastroenterologist details the indications for LT and patient selection, evaluation, liver organ allocation, prioritization for transplantation, transplantation benefit by the Model for End-Stage Liver Disease (MELD), MELD limitations, sources of liver graft, strategies employed to decrease the donor deficit, complications, and outcomes. Figures include indications for LT in Europe and the United States, Organ Procurement and Transplantation Network regions in the United States, the number of transplants and size of active waiting lists, mortality by MELD, regional disparity, patient survival rates with and without hepatitis C virus, and unadjusted patient and graft survival. Tables list LT milestones, indications for LT, contraindications for LT, minimal listing criteria for LT, criteria for LT in acute liver failure, LT evaluation process, adult recipient listing status 1A, and early posttransplantation complications. This review contains 7 highly rendered figures, 8 tables, and 46 references. 

Sign in / Sign up

Export Citation Format

Share Document